Heiner Apeler

1.6k total citations
18 papers, 1.2k citations indexed

About

Heiner Apeler is a scholar working on Molecular Biology, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Heiner Apeler has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Physiology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Heiner Apeler's work include Nitric Oxide and Endothelin Effects (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Heiner Apeler is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Heiner Apeler collaborates with scholars based in Germany, United States and Switzerland. Heiner Apeler's co-authors include Torsten Minuth, H. Schröder, Matthias Schramm, Cristina Alonso‐Alija, Klaus Dembowsky, Elisabeth Perzborn, Werner Schroeder, Wolfram Steinke, R. Gerzer and Alexander Straub and has published in prestigious journals such as Nature, Cancer Research and European Journal of Biochemistry.

In The Last Decade

Heiner Apeler

18 papers receiving 1.2k citations

Peers

Heiner Apeler
Sylvie G. Bernier United States
Barbara L. Storer United States
Angela Wirth Germany
Jeffrey B. Michel United States
Helena Hůlková Czechia
Brian N. Ling United States
Sergei D. Rybalkin United States
N. E. Owen United States
Eduard Paschke Austria
Mark Pullen United States
Sylvie G. Bernier United States
Heiner Apeler
Citations per year, relative to Heiner Apeler Heiner Apeler (= 1×) peers Sylvie G. Bernier

Countries citing papers authored by Heiner Apeler

Since Specialization
Citations

This map shows the geographic impact of Heiner Apeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heiner Apeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heiner Apeler more than expected).

Fields of papers citing papers by Heiner Apeler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heiner Apeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heiner Apeler. The network helps show where Heiner Apeler may publish in the future.

Co-authorship network of co-authors of Heiner Apeler

This figure shows the co-authorship network connecting the top 25 collaborators of Heiner Apeler. A scholar is included among the top collaborators of Heiner Apeler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heiner Apeler. Heiner Apeler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sommer, Anette, Sandra Berndt, Hans‐Georg Lerchen, et al.. (2017). Abstract 46: Preclinical activity of novel antibody-drug conjugates with pyrrole-based kinesin spindle protein inhibitors targeting different tumor antigens. Cancer Research. 77(13_Supplement). 46–46. 1 indexed citations
2.
Berndt, Sandra, Jakob Walter, Anna-Lena Frisk, et al.. (2016). Abstract 1210: Preclinical pharmacology and repeated dose toxicity of the novel agonistic TWEAK receptor binding antibody BAY-356. Cancer Research. 76(14_Supplement). 1210–1210. 1 indexed citations
3.
Ramsey, Patrick S., Liang Tang, Heiner Apeler, et al.. (2014). Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94‐9027) for haemophilia A. Haemophilia. 20(4). 593–600. 62 indexed citations
4.
Sommer, Anette, Carl F. Nising, Christoph Mahlert, et al.. (2014). Abstract 4491: FGFR2-ADC potently and selectively inhibits growth of gastric and breast cancer xenograft models. Cancer Research. 74(19_Supplement). 4491–4491. 1 indexed citations
5.
Blasko, Eric, R I Feldman, Liang Tang, et al.. (2013). Glycoengineered factor IX variants with improved pharmacokinetics and subcutaneous efficacy. Journal of Thrombosis and Haemostasis. 11(9). 1699–1706. 13 indexed citations
6.
Hristodorov, Dmitrij, et al.. (2012). Generation and Comparative Characterization of Glycosylated and Aglycosylated Human IgG1 Antibodies. Molecular Biotechnology. 53(3). 326–335. 58 indexed citations
7.
Apeler, Heiner, Jörg Peters, Werner Schröder, et al.. (2011). Expression, Purification, Biochemical and Pharmacological Characterization of a Recombinant Aprotinin Variant. Arzneimittelforschung. 54(8). 483–497. 3 indexed citations
8.
9.
Pohlscheidt, Michael, Uwe Langer, Heiner Apeler, et al.. (2008). Auslegungsunterlagen für Bioreaktoren zur Maßstabsvergößerung eines microcarrierbasierenden Virusproduktionsprozesses. Chemie Ingenieur Technik. 80(6). 821–830. 3 indexed citations
10.
Kast, R., Hartmut Schirok, Santiago Figueroa‐Pérez, et al.. (2007). Cardiovascular effects of a novel potent and highly selective azaindole‐based inhibitor of Rho‐kinase. British Journal of Pharmacology. 152(7). 1070–1080. 56 indexed citations
11.
Stasch, Johannes‐Peter, Péter Schmidt, Cristina Alonso‐Alija, et al.. (2002). NO‐ and haem‐independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. British Journal of Pharmacology. 136(5). 773–783. 251 indexed citations
12.
Stasch, Johannes‐Peter, Cristina Alonso‐Alija, Heiner Apeler, et al.. (2002). Pharmacological actions of a novel NO‐independent guanylyl cyclase stimulator, BAY 41‐8543: in vitro studies. British Journal of Pharmacology. 135(2). 333–343. 116 indexed citations
13.
Stasch, Johannes-Peter, Eva Maria Becker, Cristina Alonso‐Alija, et al.. (2001). NO-independent regulatory site on soluble guanylate cyclase. Nature. 410(6825). 212–215. 459 indexed citations
14.
Becker, Eva Maria, Cristina Alonso‐Alija, Heiner Apeler, et al.. (2001). NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272. BMC Pharmacology. 1(1). 13–13. 49 indexed citations
15.
Peters, Jörg, Kirsten Schneider, Heiner Apeler, et al.. (2000). Improving the refolding yield of interleukin-4 through the optimization of local interactions. Journal of Biotechnology. 84(3). 217–230. 12 indexed citations
16.
Hoenicka, Markus, et al.. (1999). Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide. Journal of Molecular Medicine. 77(1). 14–23. 100 indexed citations
17.
Apeler, Heiner, et al.. (1997). Expression of Natural and Synthetic Genes Encoding Herpes Simplex Virus 1 Protease in Escherichia Coli and Purification of the Protein. European Journal of Biochemistry. 247(3). 890–895. 6 indexed citations
18.
Spreyer, P., et al.. (1995). Induction ofC-FOSExpression in Rat Vascular Smooth Muscle Reporter Cells by Selective Activation of the Thrombin Receptor. Journal of Receptors and Signal Transduction. 15(1-4). 117–130. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sylvie G. Bernier Breakdown of academic impact, for papers by Barbara L. Storer Breakdown of academic impact, for papers by Angela Wirth Breakdown of academic impact, for papers by Jeffrey B. Michel Breakdown of academic impact, for papers by Helena Hůlková Breakdown of academic impact, for papers by Brian N. Ling Breakdown of academic impact, for papers by Sergei D. Rybalkin Breakdown of academic impact, for papers by N. E. Owen Breakdown of academic impact, for papers by Eduard Paschke Breakdown of academic impact, for papers by Mark Pullen
Rankless by CCL
2026